Balancing RAF, MEK, and EGFR Inhibitor Doses to Achieve Clinical Responses and Modulate Toxicity in BRAF V600E Colorectal Cancer

被引：6
作者：
Mondaca, Sebastian [1 ]
Lacouture, Mario [1 ]
Hersch, Jonathan [1 ]
Yaeger, Rona [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 300 E 66th St,10th Floor, New York, NY 10065 USA
来源：
JCO PRECISION ONCOLOGY | 2018年 / 2卷
基金：
美国国家卫生研究院;
关键词：
IMPROVED SURVIVAL; SELUMETINIB; DABRAFENIB; TRAMETINIB; MECHANISMS; MELANOMA;
D O I：
10.1200/PO.18.00088
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 4
页数：4
相关论文
共 14 条
  • [1] Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
    Bollag, Gideon
    Hirth, Peter
    Tsai, James
    Zhang, Jiazhong
    Ibrahim, Prabha N.
    Cho, Hanna
    Spevak, Wayne
    Zhang, Chao
    Zhang, Ying
    Habets, Gaston
    Burton, ElizabethA.
    Wong, Bernice
    Tsang, Garson
    West, Brian L.
    Powell, Ben
    Shellooe, Rafe
    Marimuthu, Adhirai
    Nguyen, Hoa
    Zhang, Kam Y. J.
    Artis, Dean R.
    Schlessinger, Joseph
    Su, Fei
    Higgins, Brian
    Iyer, Raman
    D'Andrea, Kurt
    Koehler, Astrid
    Stumm, Michael
    Lin, Paul S.
    Lee, Richard J.
    Grippo, Joseph
    Puzanov, Igor
    Kim, Kevin B.
    Ribas, Antoni
    McArthur, Grant A.
    Sosman, Jeffrey A.
    Chapman, Paul B.
    Flaherty, Keith T.
    Xu, Xiaowei
    Nathanson, Katherine L.
    Nolop, Keith
    [J]. NATURE, 2010, 467 (7315) : 596 - 599
  • [2] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2507 - 2516
  • [3] Combined BRAF, EGFR, and MEK Inhibition in Patients with &ITBRAF&ITV600E-Mutant Colorectal Cancer
    Corcoran, Ryan B.
    Andre, Thierry
    Atreya, Chloe E.
    Schellens, Jan H. M.
    Yoshino, Takayuki
    Bendell, Johanna C.
    Hollebecque, Antoine
    McRee, Autumn J.
    Siena, Salvatore
    Middleton, Gary
    Muro, Kei
    Gordon, Michael S.
    Tabernero, Josep
    Yaeger, Rona
    O'Dwyer, Peter J.
    Humblet, Yves
    De Vos, Filip
    Jung, A. Scott
    Brase, Jan C.
    Jaeger, Savina
    Bettinger, Severine
    Mookerjee, Bijoyesh
    Rangwala, Fatima
    Van Cutsem, Eric
    [J]. CANCER DISCOVERY, 2018, 8 (04) : 428 - 443
  • [4] Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
    Dombi, Eva
    Baldwin, Andrea
    Marcus, Leigh J.
    Fisher, Michael J.
    Weiss, Brian
    Kim, AeRang
    Whitcomb, Patricia
    Martin, Staci
    Aschbacher-Smith, Lindsey E.
    Rizvi, Tilat A.
    Wu, Jianqiang
    Ershler, Rachel
    Wolters, Pamela
    Therrien, Janet
    Glod, John
    Belasco, Jean B.
    Schorry, Elizabeth
    Brofferio, Alessandra
    Starosta, Amy J.
    Gillespie, Andrea
    Doyle, Austin L.
    Ratner, Nancy
    Widemann, Brigitte C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) : 2550 - 2560
  • [5] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
    Flaherty, Keith T.
    Robert, Caroline
    Hersey, Peter
    Nathan, Paul
    Garbe, Claus
    Milhem, Mohammed
    Demidov, Lev V.
    Hassel, Jessica C.
    Rutkowski, Piotr
    Mohr, Peter
    Dummer, Reinhard
    Trefzer, Uwe
    Larkin, James M. G.
    Utikal, Jochen
    Dreno, Brigitte
    Nyakas, Marta
    Middleton, Mark R.
    Becker, Juergen C.
    Casey, Michelle
    Sherman, Laurie J.
    Wu, Frank S.
    Ouellet, Daniele
    Martin, Anne-Marie
    Patel, Kiran
    Schadendorf, Dirk
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) : 107 - 114
  • [6] Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
    Ho, Alan L.
    Grewal, Ravinder K.
    Leboeuf, Rebecca
    Sherman, Eric J.
    Pfister, David G.
    Deandreis, Desiree
    Pentlow, Keith S.
    Zanzonico, Pat B.
    Haque, Sofia
    Gavane, Somali
    Ghossein, Ronald A.
    Ricarte-Filho, Julio C.
    Dominguez, Jose M.
    Shen, Ronglai
    Tuttle, R. Michael
    Larson, Steve M.
    Fagin, James A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (07) : 623 - 632
  • [7] Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
    Long, Georgina V.
    Stroyakovskiy, Daniil
    Gogas, Helen
    Levchenko, Evgeny
    de Braud, Filippo
    Larkin, James
    Garbe, Claus
    Jouary, Thomas
    Hauschild, Axel
    Grob, Jean-Jacques
    Chiarion-Sileni, Vanna
    Lebbe, Celeste
    Mandala, Mario
    Millward, Michael
    Arance, Ana
    Bondarenko, Igor
    Haanen, John B. A. G.
    Hansson, Johan
    Utikal, Jochen
    Ferraresi, Virginia
    Kovalenko, Nadezhda
    Mohr, Peter
    Probachai, Volodymr
    Schadendorf, Dirk
    Nathan, Paul
    Robert, Caroline
    Ribas, Antoni
    DeMarini, Douglas J.
    Irani, Jhangir G.
    Swann, Suzanne
    Legos, Jeffrey J.
    Jin, Fan
    Mookerjee, Bijoyesh
    Flaherty, Keith
    [J]. LANCET, 2015, 386 (9992) : 444 - 451
  • [8] Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
    Planchard, David
    Smit, Egbert F.
    Groen, Harry J. M.
    Mazieres, Julien
    Besse, Benjamin
    Helland, Aslaug
    Giannone, Vanessa
    D'Amelio, Anthony M., Jr.
    Zhang, Pingkuan
    Mookerjee, Bijoyesh
    Johnson, Bruce E.
    [J]. LANCET ONCOLOGY, 2017, 18 (10) : 1307 - 1316
  • [9] RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
    Poulikakos, Poulikos I.
    Zhang, Chao
    Bollag, Gideon
    Shokat, Kevan M.
    Rosen, Neal
    [J]. NATURE, 2010, 464 (7287) : 427 - U126
  • [10] Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: A case report Neurology
    Tzoulis C.
    Schwarzlmüller T.
    Gjerde I.O.
    Softeland E.
    Neckelmann G.
    Biermann M.
    Haroche J.
    Straume O.
    Vintermyr O.K.
    [J]. BMC Research Notes, 8 (1)
12